Patrick Stelmach

3PUBLICATIONS
52CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Nov 11, 2025
Response to Immune Checkpoint Blockade Is Enhanced in the Presence of Hematopoietic TET2 Inactivation.

Vincent Rondeau, Suraj Bansal, Marco M Buttigieg

|Nov 29, 2024
Multiple myeloma long-term survivors exhibit sustained immune alterations decades after first-line therapy.

Raphael Lutz, Florian Grünschläger, Malte Simon

Pageof 1